Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for type i interferons (compound)
Most Correlated Studies
- Multiple sclerosis patients receiving subcutaneous Interferon-beta-1b therapy
- IFNb1a treatment of mononuclear cells from Multiple Sclerosis patients
- Calu-3 cells responses to treatment with either IFN alpha or gamma
- Interferon-alpha-induced gene expression profiles of PBMC of patients with chronic HCV infection
- Mx1-mediated resistance to highly pathogenic influenza virus infection
Most Relevant Literature
- Differential signaling by type-I and type-III interferons in mucosa.
- Type I interferon pathway genetic variants in severe COVID-19.
- Assessment of type I interferon response in routine practice in France in 2022.
- TRIM28 facilitates type I interferon activation by targeting TBK1.
- Mechanism of action and treatment of type I interferon in hepatocellular carcinoma.
Most Relevant Clinical Trials
- A Phase 1 Study of MEDI7734 in Type I Interferon-Mediated Autoimmune Diseases
- Pronostic Value of Type I ANTi-Interferon Antibodies in Patients With COVID-19 Acute Respiratory Fai…
- A Study to Characterize the Pharmacokinetics, Pharmacodynamics, and Safety of Anifrolumab in Adult T…
- Type I Interferon Alfa-2a in Postmastectomy Breast Reconstruction
- Interferon Gamma to Treat Leukocyte Adhesion Deficiency Type I
